Corporate Profile

At Talis, we strive to deliver excellence in point of care diagnostics by increasing access to timely and accurate testing that can help combat the spread of known and emerging infectious diseases.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Press Releases

03 Nov '22
Talis Biomedical Reports Third Quarter 2022 Financial Results
REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today reported
10 May '22
Talis Biomedical Announces First Quarter 2022 Financial Results
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific MENLO PARK, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment

View More

Recent Events

View More

Executive Team

Rob Kelley

Rob Kelley

Chief Executive Officer

Roger Moody, M.B.A.

Roger Moody

Chief Financial Officer

Emily Faucette photo

Emily Faucette

Senior Vice President, Communications & IR

View More